| CAS No. | 309-29-5 |
|---|---|
| MDL No. | MFCD00242721 |
| MF | C24H30N2O2 |
| MW | 378.50 |
| InChI Key | XFDJYSQDBULQSI-UHFFFAOYSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 2 mg | 99.42% ; | $34 | In Stock | |
| 5 mg | 99.42% ; | $45 | In Stock | |
| 10 mg | 99.42% ; | $58 | In Stock | |
| 25 mg | 99.42% ; | $107 | In Stock | |
| 100 mg | 98%+;RG | $348 | In Stock | |
| 250 mg | 98%+;RG | $662 | In Stock | |
| 1 g | 98%+;RG | $1835 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Doxapram is an N-ethylpyrrolidin-2-one with two phenyl groups substituting the hydrogens at the 3 position (adjacent to the carbonyl group) and a 2-(morpholin-4-yl)ethyl group substituting one hydrogen at the 4 position. It is a central and respiratory stimulant with a brief duration of action, used as a temporary treatment for acute respiratory failure, particularly in cases of chronic obstructive pulmonary disease, and postoperative respiratory depression. It has also been used for postoperative shivering. It functions as a central nervous system stimulant and belongs to the classes of morpholines and pyrrolidin-2-ones.
| CAS No. | 309-29-5 |
|---|---|
| Product Name | Doxapram |
